Radiopharm Theranostics Ltd (RADX) Revenue (2024 - 2026)
Radiopharm Theranostics' (RADX) quarterly Revenue came in at $242356.2 in Q2 2026, up 257.81% year-over-year from $67733.5 in Q2 2025, and up 257.81% quarter-over-quarter from $67733.5 in Q2 2025.
Powered by 
Analysis
Radiopharm Theranostics Ltd (RADX) Revenue (2024 - 2026) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Revenue for 3 consecutive years, with $242356.2 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 242,356.23 |
| Jun 30, 2025 | 67,733.50 |
| Jun 30, 2024 | 236,727.53 |